🔗 Permalink

Inventor profile of:

David R. Phillips

City:

San Mateo, California

Country:

United States

Published Applications:

Last publication date:

2015-02-26

Top Assignees for applications by David R. Phillips

The entities that hold a legal rights for patent applications filed by inventor Phillips David R.:

Portola Pharmaceuticals, Inc. 11 South San Francisco, CA United States
Portola Pharmaceuticals, Inc. 4 So. San Francisco, CA United States
Millennium Pharmaceuticals, Inc. 2 Cambridge, MA United States
Portola Phamaceuticals, Inc. 1 So. San Francisco, CA United States

Recent patent applications by Phillips David R.

David R. Phillips from San Mateo, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2015-02-26

US20150057228A1

Chemistry; metallurgy

Antidotes for factor Xa inhibitors and methods of using the same

#2 | 2014-03-20

US20140079684A1

Chemistry; metallurgy

Antidotes for factor Xa inhibitors and methods of using the same

#3 | 2014-02-13

US20140044773A1

Chemistry; metallurgy

Antidotes for factor XA inhibitors and methods of using the same

#4 | 2012-10-25

US20120269788A1

Human necessities

Antidotes for factor Xa inhibitors and methods of using the same

#5 | 2012-02-02

US20120027834A1

Human necessities

Methods of treatment with Syk inhibitors

#6 | 2012-01-12

US20120009172A1

Human necessities

INTRAVENOUS AND ORAL DOSING OF A DIRECT-ACTING AND REVERSIBLE P2Y12 INHIBITOR

#7 | 2009-04-16

US20090098119A1

Human necessities

Antidotes for factor Xa inhibitors and methods of using the same

#8 | 2009-02-19

US20090048216A1

Human necessities

INTRAVENOUS AND ORAL DOSING OF A DIRECT-ACTING AND REVERSIBLE P2Y12 INHIBITOR

#9 | 2009-01-08

US20090012136A1

Human necessities

UNIT DOSE FORMULATIONS AND METHODS OF TREATING AND PREVENTING THROMBOSIS WITH THROMBOXANE RECEPTOR ANTAGONISTS

#10 | 2009-01-08

US20090012115A1

Human necessities

USE OF TP MODULATORS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS IN ASPIRIN SENSITIVE AND OTHER POPULATIONS

#11 | 2008-10-02

US20080241233A1

Human necessities

TARGETED DELIVERY AND EXPRESSION OF PROCOAGULANT HEMOSTATIC ACTIVITY

#12 | 2008-08-28

US20080207681A1

Physics

Device and methods for identifying and treating aspirin non-responsive patients

#13 | 2006-07-20

US20060160165A1

Physics

Device and methods for identifying and treating aspirin non-responsive patients

#14 | 2006-02-07

US9673302

Transgenic mammals expressing mutant GP IIIa

#15 | 2005-10-20

US20050232969A1

Human necessities

Methods of treatment with Syk inhibitors

#16 | 2005-10-11

US9775803

Transgenic animals having a modified glycoprotein V gene

InventorID:

649964 ⎘